Skip to content

Posts about Northwest Gynecology Center – Tualatin

All
What to know about hormone replacement therapy for perimenopause and menopause, and how it can help your symptoms
Danielle Weinstein, FNP-C, MSCP, MN Nov 7, 2025

What to know about hormone replacement therapy for perimenopause and menopause, and how it can help your symptoms

This article is part of WHA’s new perimenopause and menopause series. You can learn more about knowing and coping with the first signs of perimenopause, the 34 most common symptoms, menopause weight management and more. Hormone replacement therapy (HRT) is an available treatment option for many people dealing with perimenopause symptoms when the effects of…
Read more
2021 Antenatal Surveillance Guidelines
WHA Staff Mar 6, 2026

2021 Antenatal Surveillance Guidelines

Effective August 1, 2021, Northwest Perinatal Center’s Antenatal Surveillance Guidelines 2021 are intended to replace the version we made available in 2014. Similar to prior changes, please use shared decision-making with your current patients when choosing whether to keep their established care plan or to follow these new recommendations. These updated guidelines reflect updated primary…
Read more
SMFM publishes 'Things Physicians and Patients Should Question'
WHA Staff Mar 6, 2026

SMFM publishes 'Things Physicians and Patients Should Question'

The Society for Maternal-Fetal Medicine (SMFM), as part of the Choosing Wisely® campaign by the American Board of Internal Medicine (ABIM) Foundation, has, over the last year, released a list of Things Physicians and Patients Should Question. The SMFM list includes now a total of ten evidence-based recommendations that are intended to assist care providers…
Read more
Multicenter trial suggests potential benefit from the administration of antenatal corticosteroids in the late preterm period
WHA Staff Mar 6, 2026

Multicenter trial suggests potential benefit from the administration of antenatal corticosteroids in the late preterm period

The lead presentation at the SMFM Annual Meeting in February of 2016 was an evaluation of the benefit of antenatal betamethasone therapy in patients at risk of delivering in the late preterm period (34 0/7-36 6/7 weeks).(1) It was concurrently published in the NEJM. The study was a multicenter, randomized control trial by the NICHD MFMU…
Read more
Low-dose aspirin therapy for preeclampsia prevention in high-risk pregnancies
WHA Staff Mar 6, 2026

Low-dose aspirin therapy for preeclampsia prevention in high-risk pregnancies

Recently, recommendations for the use of low-dose aspirin therapy during pregnancy for the prevention of preeclampsia have expanded and evolved.  These include serial statements from both ACOG and the U.S. Preventive Services Task Force (USPSTF). The most recent recommendations from the USPSTF cite a potential 24% risk reduction with low-dose aspirin use among women at…
Read more
New workflow for suboptimally seen anatomy
WHA Staff Mar 6, 2026

New workflow for suboptimally seen anatomy

As part of Northwest Perinatal Center’s efforts to continuously improve the service that we provide our referring providers and patients, we are deploying a new process to automatically schedule patients to return for a follow-up limited anatomy evaluation when this is recommended following a fetal anatomy survey with “suboptimally seen anatomy.”  We have received several…
Read more
SMFM recommendations for counseling patients with sonographic marker for aneuploidy
WHA Staff Mar 6, 2026

SMFM recommendations for counseling patients with sonographic marker for aneuploidy

The widespread use of sonographic markers, such as echogenic intracardiac focus (EIF) or choroid plexus cyst (CPC) to assist in identifying fetuses at increased risk for common aneuploidies (trisomy 21, 18, 13) dates back to the 1980s. However, since the more recent introduction of earlier and more sensitive aneuploidy screening methods such as cell-free DNA…
Read more
NWP Antenatal Late Preterm Steroids (ALPS) Protocol
WHA Staff Mar 6, 2026

NWP Antenatal Late Preterm Steroids (ALPS) Protocol

In 2016, a multicenter trial by the NICHD MFMU Network evaluating the benefit of antenatal betamethasone therapy in patients at risk for delivering in the late preterm period (34 0/7 – 36 6/7 weeks) was published. This study suggested a modest, yet statistically significant benefit in composite respiratory outcome from betamethasone therapy when compared to…
Read more
Introducing MFM Express Didactics (MEDx) Talks
WHA Staff Mar 6, 2026

Introducing MFM Express Didactics (MEDx) Talks

Northwest Perinatal Center is pleased to announced MEDx (MFM Express Didactics) Talks. Each lecture is 15 minutes or less and deals with a focused perinatal management topic. Find the most recent talks here below and on our YouTube playlist: http://bit.ly/MEDxNWP.
Read more
An Update: Evaluation and Management of Polyhydramnios
WHA Staff Mar 6, 2026

An Update: Evaluation and Management of Polyhydramnios

Based on new recommendations from the Society for Maternal-Fetal Medicine (SMFM), Northwest Perinatal Center will no longer be recommending antenatal fetal testing or surveillance for idiopathic mild polyhydramnios (AFI 24.0 to 29.9 cm). If mild polyhydramnios is identified, NWP will continue to support you by providing appropriate fetal assessment for potential underlying structural anomalies /…
Read more

Search providers, services, locations…

Schedule an Appointment

If you’re pregnant and want to begin care at WHA–or need to schedule an appointment during your pregnancy, call us! Find a provider and location here.

Please have your insurance information handy before you begin scheduling.

This will allow our teams to check whether your plan may require a referral for the care you need or to prepare benefits information to share with you at your visit. If you do not enter insurance information when scheduling, you may be asked to pay a $200-$500 deposit before receiving service.

What type of appointment do you need?